Sophia Ononye

Sophia Ononye
Dr Sophia Ononye is an integrated marketing and communications professional with a core in scientific strategy. She recently founded The Sophia Consulting Firm where she leverages her multidisciplinary education, broad therapeutic area experience and passion for amplifying scientific innovation to lead the provision of fully integrated communication services for clients in the biotechnology, pharmaceutical and medical device space. A Yale and UCONN alumna and former Pfizer Scientist, Sophia's niche for fostering partnerships has resulted in a diverse range of experiences where she has supported emerging and established biopharmaceutical and molecular diagnostics companies with personalized marketing, launch preparedness, strategic alliance management, …
Dr Sophia Ononye is an integrated marketing and communications professional with a core in scientific strategy. She recently founded The Sophia Consulting Firm where she leverages her multidisciplinary education, broad therapeutic area experience and passion for amplifying scientific innovation to lead the provision of fully integrated communication services for clients in the biotechnology, pharmaceutical and medical device space.

A Yale and UCONN alumna and former Pfizer Scientist, Sophia's niche for fostering partnerships has resulted in a diverse range of experiences where she has supported emerging and established biopharmaceutical and molecular diagnostics companies with personalized marketing, launch preparedness, strategic alliance management, scientific communications, strategic alliance management, public relations and investor relations. She is trained in hematology and oncology with demonstrated experience in epigenetics, targeted therapies, combination therapies, checkpoint inhibitors, CAR T cell therapies and other cancer immunotherapies. Sophia also has broad therapeutic experience in rare diseases, women's health, pain management, and infectious diseases.
See more

Articles: Sophia Ononye

Exploring New & Repurposed Tools in the Fight Against COVID-19

Opinion / Dr Sophia Ononye-Onyia explains why a combination of both repurposed drugs and emerging technologies like 3D bioprinting and artificial intelligence will be crucial in beating COVID-19.   Much has already been said about the hundreds of vaccines that are currently in development for providing global protection against COVID-19 by leading research institutions and biopharmaceutical companies…

Why Technology Is Key To Surviving COVID-19

Coronavirus / Sophia Ononye-Onyia outlines the key failings in the USA’s response to the coronavirus outbreak and why greater numbers of inter-industry partnerships and increased technological uptake are key to fighting this crisis and reframing the US life sciences industry of the future.   Imagine if we invested billions in epidemiological surveillance coupled with accelerated drug discovery…

US FDA CBD Approvals Set to Soar

Opinion / Sophia Ononye outlines the history of cannabis as a medicine in the US and, following the first FDA approval of a cannabis-derived drug product in 2018, the highly promising landscape for further approvals.   The landscape for approved CBD products is highly promising and will undoubtedly lead to additional FDA approvals for the management of…

See more